SCHEMBL24310065

SCHEMBL24310065

CCc1c(Oc2cccc(N3CCN(C)CC3)c2Cl)nc(NSc2cnn(C)c2)nc1-c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 6/20 0.37
▸ DRD3 P35462 5/20 0.37
▸ DRD4 P21917 3/20 0.37
▸ HTR1A P08908 2/20 0.37
▸ HTR2A P28223 2/20 0.37
▸ HTR2C P28335 1/20 0.37
▸ PAK1 Q13153 8/20 0.34
▸ BRD4 O60885 1/20 0.33
▸ BRPF1 P55201 1/20 0.33
▸ BRD9 Q9H8M2 1/20 0.33
▸ HTR6 P50406 2/20 0.33
▸ TNIK Q9UKE5 1/20 0.33
▸ HTR7 P34969 1/20 0.33
▸ MAP3K7 O43318 1/20 0.32
▸ MAP2K1 Q02750 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ USP2 O75604 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ CASP1 P29466 1/20 0.31
▸ CASP7 P55210 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309891 0.92 PAK1 (0.35) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL24310089 0.91 DRD2 (0.35) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL24309527 0.90 DRD2 (0.39) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL24310049 0.90 PAK1 (0.36) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL24309479 0.89 HTR1A (0.33) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL24309536 0.89 BRPF1 (0.34) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL24310772 0.88 HTR1A (0.33) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL24310513 0.88 MEN1 (0.33) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL24309948 0.84 DRD2 (0.35) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL24310061 0.83 HTR1A (0.38) DRD2DRD3DRD4HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback